US10501515B2: rusfertide cross-references 69 other patent(s) via PubChem structural search (6 likely-same-scaffold hit(s))

Real cross-patent screening for US10501515B2 (Protagonist Therapeutics Inc, 'Hepcidin analogues and uses thereof'). Target compound rusfertide resolved to canonical SMILES and screened against PubChem's patent-compound index. Result: 69 unique other patents reference structurally near-identical (6 hits) or related-scaffold (6 hits) compounds. Search completed in 30.8s. Structural overlap only; no infringement conclusion stated.